BDNF and myeloid sarcoma: The administration of anti-proBDNF monoclonal antibodies (mAb-proB) can effectively improve the neurological score and reduce the number of lymphocytes in the experimental autoimmune encephalomyelitis (EAE) mouse model, a classic model of MS.